It's time to resolve it out
The Last Smile independent film has been educating viewers from continent to continent.
Watch an award winning movie highlighting dangerous OTC
Amit Zutshi Foundation is excited to announce the release of our award-winning film on various online platforms. The film won 8 awards at major international film festivals and was nominated for 3 more. This included winning the prestigious Best Feature at Burbank International film festival 2017.
The last smile is 87 minutes long independent film, presented by Amit Zutshi Foundation, highlighting the dangers of over-the-counter-supplements and the multi-billion dollar pharmaceutical industry involved in marketing these life threatening products, and one that remains totally unregulated by the FDA. The film has been written and directed by Shankey Srinivasan and has traveled to many countries in various continents (North America, Europe and Africa).
Here is your opportunity to watch it in the comfort of your home in USA, Canada and Europe.
The Amit Zutshi Foundation aims to fight use of OTC drugs and give scholarships to young people in need.
Amit Zutshi Foundation produced a Film inspired by the book The Last Smile highlighting dangers of OTC.Shankey Srinivasan, San Francisco Bay Area based Indian-American filmmaker directed the film "The Last Smile" which has earned accolades around the globe.
Author: Jeevan Zutshi ,Publisher: BookSurge (January 1, 2010)
Visit gallery of Book Signing events where dignitaries were present during an event.
Millions of people take dietary supplements every day, but have you ever thought about if they are safe or not? Newsmakers Host Barbara Rodgers interviews Jeevan Zutshi President, Amit Zutshi Foundation
action against the manufacturers
Department of Justice is taking criminal action against the manufacturers of the supplements.
Federal officials have received reports of 13 deaths over the last four years that cited the possible involvement of 5-Hour Energy, a highly caffeinated energy shot, according to Food and Drug Administration records and an interview with an agency official.